In human cancer patients, various tumor types capable of inducing pathological osteolysis have been associated with RANK-L expression, including osteosarcoma, prostatic carcinoma, breast carcinoma, multiple myeloma, and squamous cell carcinoma. Here, TNFSF11 is linked to prostate carcinoma.